The impact of the first dose of the COVID-19 vaccines

0

The first national population-level study has shed light on the effect of the first dose of the COVID-19 vaccine.

The ‘real-world’ effectiveness of the first dose of the BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 (University of Oxford–AstraZeneca) vaccines has been revealed in a prospective study of Scotland’s population of 5.4 million, covering 1.14 million vaccinations, using the EAVE II database.

READ MORE ON BIOTECHNIQUES NOW

Share:

Leave A Comment